Evidence map›Paper›PMID 35734252›Full record

ArticleFrontiers in plant science2022

Strain Construction and Process Development for Efficient Recombinant Production of Mannuronan C-5 Epimerases in

Anne Tøndervik, Randi Aune, Adelheid Degelmann, Michael Piontek, Helga Ertesvåg, Gudmund Skjåk-Bræk, Håvard Sletta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in plant science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Anne TøndervikDepartment of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
Randi AuneDepartment of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
Adelheid DegelmannARTES Biotechnology GmbH, Langenfeld, Germany.
Michael PiontekARTES Biotechnology GmbH, Langenfeld, Germany.
Helga ErtesvågDepartment of Biotechnology and Food Sciences, Trondheim, Norway.
Gudmund Skjåk-BrækDepartment of Biotechnology and Food Sciences, Trondheim, Norway.
Håvard SlettaDepartment of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.
SINTEF · NOArtes Biotechnology (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alginates are linear polysaccharides produced by brown algae and some bacteria and are composed of β-D-mannuronic acid (M) and α-L-guluronic acid (G). Alginate has numerous present and potential future applications within industrial, medical and pharmaceutical areas and G rich alginates are traditionally most valuable and frequently used due to their gelling and viscosifying properties. Mannuronan C-5 epimerases are enzymes converting M to G at the polymer level during the biosynthesis of alginate. The

Indexed as

alginateHansenula polymorphaHCDCmannuronan C-5 epimerasesrecombinant expression

Identifiers

PMID35734252
PMCPMC9208277
OpenAlexW4281705468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.